Johnson & Johnson (NYSE:JNJ) announced that its single-shot Covid-19 vaccine was 66% effective in preventing moderate and severe cases of Covid-19 in its global phase 3 trials. Updated - April 13, 2021. COVID-19: Johnson & Johnson vaccine to arrive in B.C. The first doses of Johnson & Johnson's COVID-19 vaccine are set to arrive this week in Ontario, where one expert says they could do a world of good for some of the province's most vulnerable. The FDA report said the Johnson & Johnson vaccine was similarly effective across age, race and people with comorbidities. https://www.cnn.com/2021/02/26/health/johnson-and-johnson-vaccine-effective Author of the article: David Carrigg. Moderna Vaccine . https://www.nytimes.com/2021/02/24/science/johnson-johnson-covid-vaccine.html https://www.cnn.com/2021/01/29/health/johnson-coronavirus-vaccine-results Moderna was one of the first vaccines to be approved by the FDA on December 18, 2020. Health Canada has found the Johnson and Johnson vaccine meets Canada’s stringent safety, efficacy and quality requirements #cdnpoli — Cormac Mac Sweeney (@cmaconthehill) March 5, 2021. Canada's first shipment of Johnson & Johnson's single-dose COVID-19 vaccine is expected to arrive in the coming days, but provinces are still waiting for guidance on how best to use them. New York State announced that it will follow this guidance. J&J vaccine will be the fourth available for use in Canada . Efficacy … next week . The Johnson & Johnson is approved for adults over the age of 18 at this time. Johnson & Johnson is expected to report interim data from the phase 3 trial of its Covid-19 vaccine candidate this month, providing insight into its safety and efficacy. The Johnson & Johnson vaccine is 66 percent effective at preventing COVID-19, which seems like a pretty steep drop-off from the numbers put up … https://globalnews.ca/.../7732989/johnson-johnsons-covid-19-vaccine-canada https://globalnews.ca/news/7678968/coronavirus-vaccine-efficacy However, the Johnson and Johnson vaccine efficacy rate is relatively lower than Moderna and Pfizer-BioNTech, with a 72% protective rate in the US whereas only 57% in South Africa according to StatNews. READ | Assam CM Sarbananda Sonowal takes first dose of COVID-19 vaccine. … https://www.nytimes.com/.../health/johnson-johnson-covid-19-vaccine.html Johnson & Johnson announced that its single-shot Covid-19 vaccine was 66% effective in preventing moderate and severe cases of Covid-19 in its global phase 3 trials. The CDC and FDA are reviewing data involving six cases of an extremely rare and severe type of blood clot among recipients … Today the CDC and FDA issued a statement recommending a pause in the use of the Johnson & Johnson (J&J, also known as Janssen) COVID vaccine out of an abundance of caution. The Johnson & Johnson vaccine is the first one Canada has purchased that requires just a single dose. Canada has pre-purchased 10 million doses, and has options to buy another 28 million doses. https://coronavirus.nautil.us/johnson-johnson-vaccine-efficacy https://www.vox.com/22307585/covid-19-vaccine-johnson-and-johnson-efficacy Johnson & Johnson's single-shot coronavirus vaccine protected against symptomatic and asymptomatic infection, and prevented hospitalization and death in … A study published Wednesday in the New England Journal of Medicine said the single-dose Johnson & Johnson’s Janssen COVID-19 vaccine was 67 percent effective against moderate to …